Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR).

Seys SF, Schneider S, de Kinderen J, Reitsma S, Cavaliere C, Tomazic PV, Morgenstern C, Mortuaire G, Wagenmann M, Bettio G, Ciofalo A, Diamant Z, Eckl-Dorna J, Fokkens WJ, Holzmeister C, Mariën G, Masieri S, Otten J, Scheckenbach K, Tu A, Bachert C, CHRINOSOR consortium

Open source

DOI: 10.1016/j.jaci.2024.10.016
Published: 2025 Feb
Container: The Journal of allergy and clinical immunology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jaci.2024.10.016,
  title = {Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR).},
  author = {Seys SF and Schneider S and de Kinderen J and Reitsma S and Cavaliere C and Tomazic PV and Morgenstern C and Mortuaire G and Wagenmann M and Bettio G and Ciofalo A and Diamant Z and Eckl-Dorna J and Fokkens WJ and Holzmeister C and Mariën G and Masieri S and Otten J and Scheckenbach K and Tu A and Bachert C and CHRINOSOR consortium},
  year = {2025},
  journal = {The Journal of allergy and clinical immunology},
  doi = {10.1016/j.jaci.2024.10.016},
  url = {https://doi.org/10.1016/j.jaci.2024.10.016}
}

RIS

TY  - JOUR
TI  - Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR).
AU  - Seys SF
AU  - Schneider S
AU  - de Kinderen J
AU  - Reitsma S
AU  - Cavaliere C
AU  - Tomazic PV
AU  - Morgenstern C
AU  - Mortuaire G
AU  - Wagenmann M
AU  - Bettio G
AU  - Ciofalo A
AU  - Diamant Z
AU  - Eckl-Dorna J
AU  - Fokkens WJ
AU  - Holzmeister C
AU  - Mariën G
AU  - Masieri S
AU  - Otten J
AU  - Scheckenbach K
AU  - Tu A
AU  - Bachert C
AU  - CHRINOSOR consortium
PY  - 2025
JO  - The Journal of allergy and clinical immunology
DO  - 10.1016/j.jaci.2024.10.016
UR  - https://doi.org/10.1016/j.jaci.2024.10.016
ER  -

APA

SF, S., S, S., J, D. K., S, R., C, C., PV, T., C, M., G, M., M, W., G, B., A, C., Z, D., J, E., WJ, F., C, H., G, M., S, M., J, O., K, S., A, T., C, B., & consortium, C. (2025). Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR).. The Journal of allergy and clinical immunology. https://doi.org/10.1016/j.jaci.2024.10.016

Source records

pubmed · retrieved 2026-09-25T19:13:21.202Z
europe-pmc · retrieved 2026-09-25T19:13:21.205Z